The value of arthroscopic synovectomy in the treatment of rheumatoid arthritis: A prospective cohort study
Clinical Rheumatology · 2026-08 · 45 (8) · 4889-4897
DOI: 10.1007/s10067-026-08124-9 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Rheumatology, online erschienen am 28.06.2026. Verfasst von Li-Yi Dai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Rare Disease, Department of Rheumatology and Immunology, Peking University Third Hospital, No.49 Huayuan North Road, Beijing, 100191, Chin…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Arthroscopy, Synovectomy, Knee Joint. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Clinical Key Projects of Peking University Third Hospital.
Abstract (Originalsprache)
Background
The aim of this study is to investigate the effect of arthroscopic synovectomy (AS) on disease status in patients with rheumatoid arthritis (RA).
Methods
A prospective study was conducted among patients with RA who underwent AS of the elbow or knee joints due to persistent swelling following conventional treatment, as well as control individuals who only received conventional treatment. All patients were evaluated at baseline and 4, 12, 24, 48, 96 weeks after AS. The coprimary outcomes were week 96 disease activity score (DAS)-28 remission and American College of Rheumatology improvement criteria (ACR20/50/70) remission. Key secondary outcomes were changes from baseline to week 96 in Mayo score, Lysoholm score, Health Assessment questionnaire (HAQ), patient’s visual analogue scale, Magnetic Resonance Imaging in AS group. The correlation between synovial tissue biology and clinical response was analyzed.
Results
A total of 51 patients were included, with 17 accepted AS and conventional treatment, 34 only accepted conventional treatment. At week 96, more patients in AS group achieved DAS-28 remission [52.9% (9/17) vs 11.8% (4/34), P = 0.005] and ACR70 response [35.3% (6/11) vs 5.9% (2/34), P = 0.021] compared with control group. In AS group, DAS28 score [3.9 (3.7, 4.4) vs 2.8 (2.2, 3.4), P = 0.0002], MAYO score [52.5, (45.3, 62.8) vs 72 (60. 76.3), P = 0.021], Lysoholm score [55.5 (50, 59.5) vs 67.5 (63, 78), P = 0.020] and HAQ [4 (1, 6) vs 1 (0, 2), P = 0.034] improved significantly at week 4, 4, 12 and 48 respectively, and persisted until week 96. An increase in disease activity after AS was exclusively noted in the diffuse myeloid group.
Conclusion
The disease activity and joint function of RA patients who underwent AS showed considerable improvement after surgery, which suggests that AS may enhance the likelihood of achieving remission in patients who had been treated with multiple DMARDs but have not achieved remission. Key Points • The rate of patients achieved disease remission in AS group at week 96 endpoint was better than that of the conventional treatment group. • Patients with RA after AS showed sustained improvement in disease activity and joint function, which remained stable for 96 weeks. • Only patients with diffuse myeloid synovial pathology exhibit increased disease activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Rare Disease, Department of Rheumatology and Immunology, Peking University Third Hospital, No.49 Huayuan North Road, Beijing, 100191, China.
- Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
- Department of Radiology, Peking University Third Hospital, Beijing, China.
- Center for Rare Disease, Department of Rheumatology and Immunology, Peking University Third Hospital, No.49 Huayuan North Road, Beijing, 100191, China. zhao-jinxia@163.com.
- Center for Rare Disease, Department of Rheumatology and Immunology, Peking University Third Hospital, No.49 Huayuan North Road, Beijing, 100191, China. murongster@163.com.
- Institute of Sports Medicine, Peking University Third Hospital, No.49 Huayuan North Road, Beijing, 100191, China. yyyyppvip@sina.com.
Förderung
- Clinical Key Projects of Peking University Third Hospital
Zitieren
APA
Dai, L. Y., Ren, J. Q., Zhao, Y. Q., Zhao, J. X., Mu, R., & Yang, Y. P. (2026). The value of arthroscopic synovectomy in the treatment of rheumatoid arthritis: A prospective cohort study. Clinical Rheumatology, 45(8), 4889-4897. https://doi.org/10.1007/s10067-026-08124-9
Vancouver
Dai LY, Ren JQ, Zhao YQ, Zhao JX, Mu R, Yang YP. The value of arthroscopic synovectomy in the treatment of rheumatoid arthritis: A prospective cohort study. Clinical Rheumatology. 2026;45(8):4889-4897. doi:10.1007/s10067-026-08124-9
BibTeX
@article{Dai2026,
author = {Dai, Li-Yi and Ren, Jia-Qi and Zhao, Yu-Qing and Zhao, Jin-Xia and Mu, Rong and Yang, Yu-Ping},
title = {The value of arthroscopic synovectomy in the treatment of rheumatoid arthritis: A prospective cohort study},
journal = {Clinical Rheumatology},
year = {2026},
volume = {45},
number = {8},
pages = {4889--4897},
doi = {10.1007/s10067-026-08124-9}
}
EUVIMED